Search

everythinglearnresearchcommunity

for

Search:↓

Severe baldness on the top of the head is linked to a higher chance of heart disease, especially in men under 60.

Oral dutasteride works better for hair loss, but has more sexual side effects; intralesional dutasteride is a possible alternative.

Medroxyprogesterone acetate iontophoresis safely and effectively reduces facial hair growth in women.

A new topical treatment using SAMiRNA technology shows promise in increasing hair growth for androgenetic alopecia.

Certain gene variations are linked to a higher risk of severe acne, suggesting a genetic influence on the condition.

Chronic kidney disease can cause hair loss, which may be related to zinc deficiency or certain medications, and sometimes hair grows back when the underlying issue is treated.

Some conditions mimic PCOS symptoms and need careful diagnosis to treat potentially serious health issues.

The study concluded that hair loss in Indian women is not significantly linked to anemia or thyroid problems, but checking thyroid function could help those with ongoing hair loss.

No significant hormone differences found in postmenopausal women with androgenetic alopecia.

The document explains different hair and scalp conditions, including common hair loss after pregnancy or illness, drug-induced hair loss, hereditary excessive hair growth, patterned baldness, autoimmune hair loss, and permanent loss due to skin disease, with generally limited treatment options.

Skin problems like psoriasis and systemic sclerosis can increase the risk of heart disease, so doctors should watch for heart risks in patients with these conditions.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

SHBG may be a useful early indicator and treatment target for PCOS.

Scalp hair thinning in women with PCOS is linked to metabolic issues like abnormal glucose tolerance, high LDL, and skipped meals.

Finasteride and minoxidil are effective for hair loss, but continued research is needed for better treatments.

AGA causes hair loss by shrinking hair follicles due to DHT binding, and can be treated with finasteride and minoxidil.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

Effective treatments for male pattern baldness include oral finasteride and topical minoxidil, while topical minoxidil is best for female pattern baldness.

Over one-third of women experience hair loss, with female-pattern hair loss being most common, and treatments include minoxidil and possibly hair transplantation.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

Spironolactone is an effective and well-tolerated first-line treatment for hidradenitis suppurativa in women.

Obese women with PCOS are more likely to have fatty liver disease.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Female pattern hair loss involves hormonal factors, genetics, and may be linked to low ferritin levels.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

Over half of the adult women with acne in the study had higher than normal levels of male hormones, especially DHEA.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

Most patients improved with oral contraceptives, but some needed additional treatment.